These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 21170825

  • 1. Oxytocin antagonists for the management of preterm birth: a review.
    Usta IM, Khalil A, Nassar AH.
    Am J Perinatol; 2011 Jun; 28(6):449-60. PubMed ID: 21170825
    [Abstract] [Full Text] [Related]

  • 2. Emerging tocolytics for maintenance therapy of preterm labour: oxytocin antagonists and calcium channel blockers.
    Kim A, Shim JY.
    BJOG; 2006 Dec; 113 Suppl 3():113-5. PubMed ID: 17206978
    [Abstract] [Full Text] [Related]

  • 3. [Clinical experience of using oxytocin antagonist atosiban in the rescue therapy of preterm labour].
    Tan JP, Chen H, Du BJ, Liu YL, Wang YH, Zhang JP.
    Zhonghua Fu Chan Ke Za Zhi; 2008 Feb; 43(2):81-4. PubMed ID: 18683742
    [Abstract] [Full Text] [Related]

  • 4. The effects of the tocolytics atosiban and nifedipine on fetal movements, heart rate and blood flow.
    de Heus R, Mulder EJ, Derks JB, Visser GH.
    J Matern Fetal Neonatal Med; 2009 Jun; 22(6):485-90. PubMed ID: 19479644
    [Abstract] [Full Text] [Related]

  • 5. Developments in the pharmacotherapeutic management of spontaneous preterm labor.
    Kam KY, Lamont RF.
    Expert Opin Pharmacother; 2008 May; 9(7):1153-68. PubMed ID: 18422473
    [Abstract] [Full Text] [Related]

  • 6. The oxytocin antagonist atosiban versus the beta-agonist terbutaline in the treatment of preterm labor. A randomized, double-blind, controlled study.
    European Atosiban Study Group.
    Acta Obstet Gynecol Scand; 2001 May; 80(5):413-22. PubMed ID: 11328217
    [Abstract] [Full Text] [Related]

  • 7. Calcium channel blockers for the management of preterm birth: a review.
    Nassar AH, Aoun J, Usta IM.
    Am J Perinatol; 2011 Jan; 28(1):57-66. PubMed ID: 20640972
    [Abstract] [Full Text] [Related]

  • 8. Barusiban suppresses oxytocin-induced preterm labour in non-human primates.
    Reinheimer TM.
    BMC Pregnancy Childbirth; 2007 Jun 01; 7 Suppl 1(Suppl 1):S15. PubMed ID: 17570159
    [Abstract] [Full Text] [Related]

  • 9. Atosiban.
    Shubert PJ.
    Clin Obstet Gynecol; 1995 Dec 01; 38(4):722-4. PubMed ID: 8616970
    [Abstract] [Full Text] [Related]

  • 10. Treatment of preterm labor with the oxytocin antagonist atosiban.
    Goodwin TM, Valenzuela G, Silver H, Hayashi R, Creasy GW, Lane R.
    Am J Perinatol; 1996 Apr 01; 13(3):143-6. PubMed ID: 8688103
    [Abstract] [Full Text] [Related]

  • 11. The safety of tocolytics used for the inhibition of preterm labour.
    Lamont CD, Jørgensen JS, Lamont RF.
    Expert Opin Drug Saf; 2016 Sep 01; 15(9):1163-73. PubMed ID: 27159501
    [Abstract] [Full Text] [Related]

  • 12. Effect of nifedipine and atosiban on perinatal brain injury: secondary analysis of the APOSTEL-III trial.
    Nijman TAJ, Goedhart MM, Naaktgeboren CN, de Haan TR, Vijlbrief DC, Mol BW, Benders MJN, Franx A, Oudijk MA.
    Ultrasound Obstet Gynecol; 2018 Jun 01; 51(6):806-812. PubMed ID: 28452086
    [Abstract] [Full Text] [Related]

  • 13. Nifedipine versus atosiban for threatened preterm birth (APOSTEL III): a multicentre, randomised controlled trial.
    van Vliet EOG, Nijman TAJ, Schuit E, Heida KY, Opmeer BC, Kok M, Gyselaers W, Porath MM, Woiski M, Bax CJ, Bloemenkamp KWM, Scheepers HCJ, Jacquemyn Y, Beek EV, Duvekot JJ, Franssen MTM, Papatsonis DN, Kok JH, van der Post JAM, Franx A, Mol BW, Oudijk MA.
    Lancet; 2016 May 21; 387(10033):2117-2124. PubMed ID: 26944026
    [Abstract] [Full Text] [Related]

  • 14. Maintenance treatment of preterm labor with the oxytocin antagonist atosiban. The Atosiban PTL-098 Study Group.
    Valenzuela GJ, Sanchez-Ramos L, Romero R, Silver HM, Koltun WD, Millar L, Hobbins J, Rayburn W, Shangold G, Wang J, Smith J, Creasy GW.
    Am J Obstet Gynecol; 2000 May 21; 182(5):1184-90. PubMed ID: 10819856
    [Abstract] [Full Text] [Related]

  • 15. Oxytocin and vasopressin V(1A) receptors as new therapeutic targets in assisted reproduction.
    Pierzynski P.
    Reprod Biomed Online; 2011 Jan 21; 22(1):9-16. PubMed ID: 21130036
    [Abstract] [Full Text] [Related]

  • 16. Oxytocin and fetal membranes in preterm labor: current concepts and clinical implication.
    Laudanski T, Pierzynski P.
    Gynecol Endocrinol; 2003 Jun 21; 17(3):261-7. PubMed ID: 12857435
    [Abstract] [Full Text] [Related]

  • 17. Atosiban for preterm labour.
    Tsatsaris V, Carbonne B, Cabrol D.
    Drugs; 2004 Jun 21; 64(4):375-82. PubMed ID: 14969573
    [Abstract] [Full Text] [Related]

  • 18. [Atosiban treatment for preterm labor--financial considerations and savings by implementing clinical guidelines].
    Hadar E, Mansur N, Ambar I, Hod M.
    Harefuah; 2011 Jun 21; 150(6):502-6, 553. PubMed ID: 21800486
    [Abstract] [Full Text] [Related]

  • 19. Preterm labor: current tocolytic options for the treatment of preterm labor.
    Jørgensen JS, Weile LK, Lamont RF.
    Expert Opin Pharmacother; 2014 Apr 21; 15(5):585-8. PubMed ID: 24456411
    [Abstract] [Full Text] [Related]

  • 20. Medical therapy in the management of preterm birth.
    Meloni A, Melis M, Alba E, Deiana S, Atzei A, Paoletti AM, Capobianco G, Dessole S, Melis GB.
    J Matern Fetal Neonatal Med; 2009 Apr 21; 22 Suppl 3():72-6. PubMed ID: 19925364
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.